Spots Global Cancer Trial Database for cmf regimen
Every month we try and update this database with for cmf regimen cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| S9716: Combination Chemotherapy in Treating Patients With Merkel Cell Cancer | NCT00003549 | Neuroendocrine ... | CMF regimen cyclophosphamid... fluorouracil methotrexate | 18 Years - | SWOG Cancer Research Network | |
| Standard Chemotherapy Compared With High-Dose Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Women With Advanced or Inflammatory Breast Cancer | NCT00003680 | Breast Cancer | CMF regimen cyclophosphamid... fluorouracil methotrexate tamoxifen citra... thiotepa peripheral bloo... radiation thera... | 18 Years - 60 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy With Trastuzumab in Treating Women With Metastatic Breast Cancer | NCT00036868 | Breast Cancer | trastuzumab CMF regimen cyclophosphamid... fluorouracil methotrexate | 18 Years - 120 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer | NCT00002582 | Breast Cancer | CMF regimen cyclophosphamid... doxorubicin hyd... fluorouracil goserelin aceta... leuprolide acet... methotrexate tamoxifen citra... oophorectomy radiation thera... | - | National Cancer Institute (NCI) | |
| S9716: Combination Chemotherapy in Treating Patients With Merkel Cell Cancer | NCT00003549 | Neuroendocrine ... | CMF regimen cyclophosphamid... fluorouracil methotrexate | 18 Years - | SWOG Cancer Research Network | |
| Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Chemotherapy Alone in Treating Women With Stage IV Breast Cancer | NCT00012311 | Breast Cancer | filgrastim CMF regimen carboplatin cyclophosphamid... docetaxel doxorubicin hyd... etoposide fluorouracil ifosfamide methotrexate thiotepa peripheral bloo... | 18 Years - 59 Years | National Cancer Institute (NCI) | |
| Tamoxifen in Treating Women With High-Risk Breast Cancer | NCT00002542 | Breast Cancer | CMF regimen cyclophosphamid... doxorubicin hyd... epirubicin hydr... fluorouracil methotrexate tamoxifen citra... radiation thera... | - 120 Years | Canadian Cancer Trials Group | |
| Combination Chemotherapy With or Without Epirubicin in Treating Women With Stage I or Stage II Breast Cancer | NCT00003577 | Breast Cancer | CMF regimen cyclophosphamid... epirubicin hydr... fluorouracil methotrexate adjuvant therap... radiation thera... | - | National Cancer Institute (NCI) | |
| Chemotherapy Plus Surgery in Treating Women With Breast Cancer | NCT00003013 | Breast Cancer | CMF regimen cyclophosphamid... doxorubicin hyd... fluorouracil methotrexate paclitaxel tamoxifen citra... conventional su... radiation thera... | 18 Years - 70 Years | National Cancer Institute (NCI) | |
| Standard Chemotherapy Compared With High-Dose Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Women With Advanced or Inflammatory Breast Cancer | NCT00003680 | Breast Cancer | CMF regimen cyclophosphamid... fluorouracil methotrexate tamoxifen citra... thiotepa peripheral bloo... radiation thera... | 18 Years - 60 Years | National Cancer Institute (NCI) | |
| Adjuvant Chemotherapy Plus Radiation Therapy in Treating Women With Early-Stage Breast Cancer | NCT00003893 | Breast Cancer | CMF regimen cyclophosphamid... doxorubicin hyd... epirubicin hydr... fluorouracil methotrexate mitomycin C mitoxantrone hy... adjuvant therap... radiation thera... | - | National Cancer Institute (NCI) | |
| Combination Chemotherapy Compared With Mitoxantrone in Treating Older Patients With Advanced Breast Cancer | NCT00002498 | Breast Cancer | CMF regimen cyclophosphamid... fluorouracil methotrexate mitoxantrone hy... | 70 Years - | National Cancer Institute (NCI) | |
| Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Chemotherapy Alone in Treating Women With Stage IV Breast Cancer | NCT00012311 | Breast Cancer | filgrastim CMF regimen carboplatin cyclophosphamid... docetaxel doxorubicin hyd... etoposide fluorouracil ifosfamide methotrexate thiotepa peripheral bloo... | 18 Years - 59 Years | National Cancer Institute (NCI) | |
| Combination Chemotherapy Compared With Mitoxantrone in Treating Older Patients With Advanced Breast Cancer | NCT00002498 | Breast Cancer | CMF regimen cyclophosphamid... fluorouracil methotrexate mitoxantrone hy... | 70 Years - | National Cancer Institute (NCI) | |
| Tamoxifen Following Combination Chemotherapy in Treating Women With Operable Invasive Breast Cancer | NCT00002579 | Breast Cancer | CMF regimen cyclophosphamid... fluorouracil methotrexate tamoxifen citra... conventional su... radiation thera... | - | National Cancer Institute (NCI) | |
| Combination Chemotherapy Following Surgery in Treating Women With Early Stage Breast Cancer | NCT00003012 | Breast Cancer | CMF regimen cyclophosphamid... epirubicin hydr... fluorouracil methotrexate | - | National Cancer Institute (NCI) | |
| Combination Chemotherapy in Treating Women With Resected Breast Cancer | NCT00033683 | Breast Cancer | CMF regimen cyclophosphamid... docetaxel epirubicin hydr... fluorouracil methotrexate tamoxifen citra... adjuvant therap... radiation thera... | 18 Years - | National Cancer Institute (NCI) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
